These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2278282)

  • 1. Ciprofloxacin as an alternative to i.v. therapy.
    Fazio A
    Am J Hosp Pharm; 1990 Dec; 47(12):2660. PubMed ID: 2278282
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of ciprofloxacin in gynaecological infections.
    Loendersloot E; Branolte JH
    J Chemother; 1989 Jul; 1(4 Suppl):888-9. PubMed ID: 16312688
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
    De Wilde R
    J Chemother; 1989 Jul; 1(4 Suppl):896-7. PubMed ID: 16312693
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin: major advances in intravenous and oral quinolone therapy. Proceedings of a symposium. April 28 to 29, 1989, Naples, Florida.
    Am J Med; 1989 Nov; 87(5A):1S-287S. PubMed ID: 2589353
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy.
    Powers T; Bingham DH
    Am J Hosp Pharm; 1990 Aug; 47(8):1781-4. PubMed ID: 2389785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ciprofloxacin vs intravenous therapy with nonquinolone agents. A study of 291 infections.
    Lorian V; Pavletich K
    Drugs; 1995; 49 Suppl 2():477-9. PubMed ID: 8549406
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of oral fluoroquinolones as an alternative to traditional parenteral therapy for patients with serious infections.
    Ball P
    Clin Invest Med; 1989 Feb; 12(1):69-70. PubMed ID: 2920483
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow-up therapy with ciprofloxacin in severe infection, an alternative to parenteral treatment.
    Bassaris HP; Chrysanthopoulos CJ; Skouelis AT; Starakis JC
    J Chemother; 1989 Jul; 1(4 Suppl):676-7. PubMed ID: 16312588
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI).
    Naccari F; Salpietro DC; De Sarro A; Masaracchio A; Barberi I
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):187-92. PubMed ID: 9583092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ciprofloxacin in long-lasting otorrhea.
    Manestar D; Braut T; Velepic M
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):236. PubMed ID: 10037296
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
    Leblanc M
    Clin Nephrol; 1997 May; 47(5):350. PubMed ID: 9181286
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].
    Hong SN; Kim BJ; Lee SY; Lee CY; Ryu MK; Choi MS; Lee JH; Rhee PL; Koh KC; Kim JJ; Paik SW; Rhee JC; Choi KW
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):288-96. PubMed ID: 12499786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin treatment of acute infections in immunocompromised host.
    Nemes G; Heuser Y; Stolle D; Piroth HD; Nemes P
    J Chemother; 1989 Jul; 1(4 Suppl):722-3. PubMed ID: 16312607
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of oral antimicrobials for the management of intra-abdominal infections.
    Solomkin JS; Dellinger EP; Bohnen JM; Rostein OD
    New Horiz; 1998 May; 6(2 Suppl):S46-52. PubMed ID: 9654311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.
    Hsieh WJ; Lin HC; Hwang SJ; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 1998 Jun; 93(6):962-6. PubMed ID: 9647029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Olapade-Olaopa EO; Adebayo SA
    J Urol; 2006 Jun; 175(6):2365-6; author reply 2366. PubMed ID: 16697876
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
    Goffin E; Pouthier D; Vandercam B; Gigi J; van Ypersele de Strihou C
    Clin Nephrol; 1997 Dec; 48(6):391-2. PubMed ID: 9438101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.